Professor Mike Dixon

Professor Dixon Says "Breakthrough fund the first and only dedicated breast cancer research unit in Scotland, at the Western General Hospital in Edinburgh.   The work is focused on improving treatment for women with hormone-sensitive breast cancer, the most common form of the disease. 

Being a breast surgeon and also working in the laboratory there, I know how important it is to translate laboratory findings into direct benefits for patients and this type of research allows us to do this quickly and effectively.  This could make a real difference to the thousands of women diagnosed with breast cancer each year in Scotland and the rest of the UK."

More About Professor Dixon

Professor Mike Dixon is a fellow of The Royal College of Surgeons of Edinburgh and England and an honorary fellow of The Royal College of Physicians of Edinburgh. He was appointed as Consultant Surgeon/Senior Lecturer in Surgery in October 1994 and has been leader of the research performed in the Edinburgh Breast Unit since that date.

Professor Dixon is a member of the British Breast Group, the Scottish Cancer Trials Breast Group, the South East of Scotland Cancer Area Network Breast Cancer Group and the European Association for Cancer Research. He is a panel member of the UK National Breast Cancer Coalition, and a representative on the Central European Cooperative Oncology Group. He is a member of the organising committee of the Nottingham International Breast Cancer Conference, the SIGN Guidelines committee and a medical advisor to Breast Cancer Care and CancerBACUP.

Professor Dixon’s research work focuses exclusively on breast disease and principally on the hormonal treatment of breast cancer. Professor Dixon was involved in the introduction of many of the newer agents now used in the treatment of breast cancer.